Welcome to BDA

  "The future of molecular targeted therapy requires a detailed understanding of translational R&D and economics."


Home Navigation Navigation Pre-clinical Navigation Clinical Navigation News Navigation Events Navigation Links Navigation Contacts Navigation Information

    Wed 08 Sep 2010

Latest BDA Events
8th – 10th September 2010
Biotherapy of Cancer (BTOC 10)
Klinikum der Universität München
Programme
Register
_______________________

Latest events

 
BDA Information
Click here to request information from BDA

Change text size

© 2009 Biotherapy Development Association




Organisation
The BDA is comprised of board and general members, scientific panels, a strategic working group, a global network of clinical centres, plus laboratories to handle pre-clinical and clinical work.

BDA Board The BDA Board Members meet regularly to discuss and review research goals and new proposals.

Scientific Panel The BDA Scientific Panel consists of experts from both within the BDA and from external centres, covering all areas in biotherapy. This provides great flexibility and enables the BDA to call on expertise from a large number of scientific and clinical disciplines.

Trial Conduct at BDA The BDA assigns one or more lead study coordinators to each clinical trial who assume responsibility for it's efficient execution.

Collaboration The BDA enjoys collaboration with many regulatory authorities, industry, patient groups and academia and host regular meetings to allow practical interfaces to allow practical interfaces to take place and to engender effective networking.


Web site created and maintained using   link to web4work